Ken Griffin’s Clearmind Medicine CMND Stock Holding History

Ken Griffin’s Portfolio CMND Stock Details CMND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-95	Closed	-$52.7K	–	14593
2024 Q4	$52.7K	Buy	95 +51	+116%	+$28.3K	﹤0.01%	12344
2024 Q3	$21.6K	Buy	+44	New	+$25K	﹤0.01%	12720
2023 Q4	–	Sell	-1	Closed	-$2.35K	–	14351
2023 Q3	$2.35K	Sell	1 -2	-67%	-$9.16K	﹤0.01%	13732
2023 Q2	$17.4K	Buy	3 +2	+200%	+$13.5K	﹤0.01%	12848
2023 Q1	$13.1K	Buy	+1	New	+$41.7K	﹤0.01%	13378

Other funds holding CMND

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

CWG

Cornerstone Wealth Group Huntersville, North Carolina $1.69B AUM 28.24% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Ken Griffin's CMND Position: Q1 2025 in Review

Ken Griffin sold out of Clearmind Medicine (CMND) in Q1 2025, closing a stake of 95 shares — an estimated $52.7K sold.

Ken Griffin first reported a position in CMND in Q1 2023 and held it in 5 quarters. The position peaked at $52.7K in Q4 2024. 7 funds tracked by Wall St. Rank hold CMND as of Q1 2025.

Ken Griffin reported no remaining Clearmind Medicine position as of Q1 2025 after selling out during the quarter.
Ken Griffin sold 95 Clearmind Medicine shares in Q1 2025, an estimated $52.7K.
Ken Griffin first reported a position in Clearmind Medicine in Q1 2023 and held it in 5 quarters.
Ken Griffin's Clearmind Medicine position peaked at $52.7K in Q4 2024.
7 funds tracked by Wall St. Rank held Clearmind Medicine as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.